Fresh raw wildflower honey, particularly at concentrations of 10–30%, exhibit comparable efficacy to manuka honey in inhibiting antibiotic-resistant "superbugs" implicated in wound infections, offering a potentially cost-effective alternative for wound care in the United States.
Network Pharmacology Antibacterial Antimicrobial Honey
Postoperative infections, a significant concern in US hospitals, often involve drug-resistant wound-infecting bacteria, contributing to life-threatening complications. Manuka honey, FDA-approved for wound treatment, has demonstrated antibacterial efficacy. This study sought alternative honey types for wound infections. Using a honey-plate method, it identified fresh raw Arkansas wildflower honeys as effective against antibiotic-resistant bacteria, mirroring manuka honey's inhibition. Concentrations of 10–30% honey proved effective against critical "superbugs," indicating potential cost-effective alternatives for wound care in the US, where manuka honey accessibility and antibiotic resistance are challenges.
The study presents a promising revelation: fresh raw Arkansas wildflower honeys, akin to manuka honey, exhibit substantial efficacy against antibiotic-resistant bacteria implicated in wound infections. The demonstrated effectiveness at concentrations of 10–30% suggests a feasible and cost-effective alternative for wound care in the US, addressing challenges associated with manuka honey availability and antibiotic resistance. These findings have the potential to reshape wound treatment practices, providing accessible and efficient solutions to combat infections caused by drug-resistant bacteria.
View Article